Your browser doesn't support javascript.
loading
BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM.
Battin, Claire; Leitner, Judith; Waidhofer-Söllner, Petra; Grabmeier-Pfistershammer, Katharina; Olive, Daniel; Steinberger, Peter.
Afiliação
  • Battin C; Division of Immune Receptors and T Cell Activation, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Leitner J; Division of Immune Receptors and T Cell Activation, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Waidhofer-Söllner P; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Grabmeier-Pfistershammer K; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Olive D; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; Centre National de la Recherche Scientifique (CNRS), UMR7258; Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
  • Steinberger P; Division of Immune Receptors and T Cell Activation, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Front Immunol ; 13: 956694, 2022.
Article em En | MEDLINE | ID: mdl-36081508

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Linfócitos T / Membro 14 de Receptores do Fator de Necrose Tumoral Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Linfócitos T / Membro 14 de Receptores do Fator de Necrose Tumoral Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria